SCHEMBL2277112

SCHEMBL2277112

CN(C)/C=N/c1ncc[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.38
ALDH1A1 P00352 5/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 2/20 0.34
KDM4E B2RXH2 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 3/20 0.33
MAPK1 P28482 2/20 0.33
MEN1 O00255 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NPC1 O15118 1/20 0.33
HSP90AA1 P07900 1/20 0.33
AGTR1 P30556 1/20 0.33
RAB9A P51151 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32
LMNA P02545 1/20 0.32
ALOX15 P16050 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2277116 1.00 L3MBTL1 (0.38) L3MBTL1ALDH1A1SMN1; SMN2GAAKDM4E
SCHEMBL14062519 0.77
SCHEMBL5500536 0.77
SCHEMBL22947098 0.73
SCHEMBL5487957 0.70 MEN1 (0.52) ALDH1A1SMN1; SMN2KDM4EKMT2AMAPT
SCHEMBL11103862 0.70 MEN1 (0.52) ALDH1A1SMN1; SMN2KDM4EKMT2AMAPT
SCHEMBL11107953 0.70 MEN1 (0.52) ALDH1A1SMN1; SMN2KDM4EKMT2AMAPT
SCHEMBL441370 0.69 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2KDM4EKMT2AMAPT
SCHEMBL16547018 0.69 L3MBTL1 (0.35) L3MBTL1GAAKDM4EKMT2AMAPT
SCHEMBL1752174 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059231-A1 Protease inhibitors PROTINHI B.V. (NL) 2025-02-20 US disclosed
EP-4408454-A1 PROTEASE INHIBITORS Protinhi B.V. (NL) 2024-08-07 EP disclosed
EP-3512604-B1 STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE WELLA OPERATIONS US LLC (US) 2023-05-31 EP disclosed
WO-2023052636-A1 PROTEASE INHIBITORS PROTINHI B.V. (NL) 2023-04-06 WO disclosed
EP-3512604-A1 STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE Noxell Corporation (US) 2019-07-24 EP disclosed
US-10093807-B2 Stable yellow imidazolium compounds NOXELL CORPORATION (US) 2018-10-09 US disclosed
US-20180078477-A1 Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds WELLA OPERATIONS US, LLC 2018-03-22 US disclosed
US-20180078477-A1 Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds WELLA OPERATIONS US, LLC 2018-03-22 US disclosed
WO-2018053027-A1 STABLE YELLOW IMIDAZOLIUM COMPOUNDS AND METHODS FOR THEIR USE NOXELL CORPORATION (US) 2018-03-22 WO disclosed
US-20180079907-A1 Stable Yellow Imidazolium Compounds WELLA OPERATIONS US, LLC 2018-03-22 US disclosed
US-20180079907-A1 Stable Yellow Imidazolium Compounds WELLA OPERATIONS US, LLC 2018-03-22 US disclosed
US-9918919-B1 Method of coloring hair with washfast yellow imidazolium direct dye compounds NOXELL CORPORATION (US) 2018-03-20 US disclosed
US-9918919-B1 Method of coloring hair with washfast yellow imidazolium direct dye compounds NOXELL CORPORATION (US) 2018-03-20 US disclosed
US-9918919-B1 Method of coloring hair with washfast yellow imidazolium direct dye compounds NOXELL CORPORATION (US) 2018-03-20 US disclosed
US-7998462-B2 Linkers for anchoring targeting ligands KEREOS, INC. (US) 2011-08-16 US disclosed
US-7998462-B2 Linkers for anchoring targeting ligands KEREOS, INC. (US) 2011-08-16 US disclosed
US-20080305037-A1 LINKERS FOR ANCHORING TARGETING LIGANDS KEREOS, INC. 2008-12-11 US disclosed
WO-2008070291-A2 IMPROVED LINKERS FOR ANCHORING TARGETING LIGANDS KEREOS, INC. (US) 2008-06-12 WO disclosed
US-5552427-A ANTITUMOR AGENTS AND ANTICARCINOGENIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-09-03 US disclosed
EP-0656210-A1 Imidazole derivatives as glutaminose inhibitors Takeda Chemical Industries, Ltd. (JP) 1995-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305037-A1 LINKERS FOR ANCHORING TARGETING LIGANDS LDLR, HDLBP, FABP1 L3MBTL1 512/4885ALDH1A1 3313/4885SMN1; SMN2 4043/4885
US-20180078477-A1 Method of Coloring Hair with Washfast Yellow Imidazolium Direct Dye Compounds WASHC4, TYR, WASHC5 L3MBTL1 4542/4885ALDH1A1 228/4885SMN1; SMN2 4506/4885
US-20250059231-A1 Protease inhibitors PREP, DNPEP, TMPRSS15 L3MBTL1 533/4885ALDH1A1 3986/4885SMN1; SMN2 2297/4885
US-10093807-B2 Stable yellow imidazolium compounds IK, NDUFV1, NDUFV2 L3MBTL1 4037/4885ALDH1A1 1345/4885SMN1; SMN2 1599/4885
US-20180079907-A1 Stable Yellow Imidazolium Compounds IK, NDUFV1, NDUFV2 L3MBTL1 4037/4885ALDH1A1 1345/4885SMN1; SMN2 1599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.